|
A prospective observational study of probiotics in chronic kidney disease.
|
|
| Author:
|
J. KIRUBAKARAN, V. HEMANTH KUMAR, CH. NEELIMA PRIYA, Y. RAMA PRIYANKA , N. SATHYANARAYANA, M.D. DHANARAJU
|
| Abstract:
|
Chronic kidney disease is a prominent disease that is commonly observed in elderly patients but it may also observe in young adults of age between 19 to 40 years. When there is a progressive loss of kidney function, the toxins accumulate in most of the vital organs of the body which leads to inflammation and eventually, organ damage. Serum creatinine, blood urea nitrogen, uric acids are some of the uremic toxins and also include p-cresol sulfate and indoxyl sulfate. Our study is to find out the effectiveness of lactobacillus which is commercially available at low cost, by comparing with the standard recommended strains of probiotics which are high in cost. The study was conducted for about 6 months where patients were divided into two groups. One group was prescribed with standard strains and another with commercially lactobacillus. Parameters were compared before and after the treatment period. The obtained data were analysed by using the statistical method. About 100 patients were included in the study where 84 patients had completed the study successfully in which 62 were male and 22 were female from the age group of 40-70. The mean age of patients in probio-1 is 62.5 ±22.5 and in probio-2 is 57.5 ±17.5. These probiotics show a significant decrease in the blood urea nitrogen and there is no declination of serum Creatinine and uric acid. When probiotics were compared based on effectiveness, the specific strains show a significant effect in decreasing the uremic toxins when compared to commercial lactobacillus strain.
|
| Keyword:
|
Chronic kidney disease, Probiotics, Uremic toxins, Streptococcus thermophilus, Lactobacillus acidophilus, and Bifidobacterium longum.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2020.12.02.0006
|
| Download:
|
Request For Article
|
|
|